Skip to main content

July 2024

 

 

academics

 

Clinical research courses

Zydus and Roche legal battle highlights need for affordable breast cancer treatments in India, says GlobalData

Zydus Life Sciences is engaged in a legal battle with Roche over its biosimilar, Sigrima, which is based on Roches Perjeta Pertuzumab, targeting the human epidermal growth factor receptor 2-positive breast cancer market in India.
Action is taken against companies found selling formulations at prices higher than the permissible price
As per the provisions of Drugs Order, 2013 , formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule –I are defined under Para of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013.
Government of India schemes to encourage startups in pharmaceutical sector
Startup India Initiative, launched on January 16, 2016, which aims to foster innovation and encourage investments across various industries, including the pharmaceutical sector. The initiative includes three flagship schemes viz., Fund of Funds for Startups; Startup India Seed Fund Scheme; and Credit Guarantee Scheme for Startups
The virus that causes COVID-19 is widespread in wildlife : Scientists find

SARS-CoV-2, the virus responsible for COVID-19, is widespread among wildlife species, according to Virginia Tech research published today in Nature Communications. The virus was detected in six common backyard species and antibodies indicating prior exposure to the virus were found in five species with rates of exposure ranging from 40 to 60 percent depending on the species.

Improving the Design of mRNA-loaded Nanocarriers for Targeted Therapies

Substituting amines with phosphonium-based cations could greatly improve the performance of mRNA-loaded polymeric micelles, report scientists from Tokyo Tech. By adopting this innovative strategy, they managed to enhance the stability and mRNA-delivery capabilities of micelle nanocarriers into tumor tissue in vivo. Their results hint at the importance of exploring other cations besides amines in mRNA drug delivery and could pave the way to effective treatment for challenging diseases.

Opportunity for M.Pharm, MSc or B.Pharm as CRO, Data Analyst at BITS
Master degree MSc, MS, M.Pharm or equivalent in life sciences or related discipline with clinical research experience and knowledge of biostatistics. Bachelor's degree BSc, BS, B.Pharm or equivalent in life sciences or related discipline with several years of experience in clinical research will be given due consideration as well.
Vacancy for Pharmacist at District Health Society Botad

NHM at District Health Society, Botad, An advertisement is hereby given to fill the following posts on contractual basis of 11 months and to prepare a waiting list for the posts that fall vacant in the future. Interested candidates having required qualification for the said post may apply through Arogya Sathi software link arogyasathi.gujarat.gov.in on 29/07/2024 from 12:00 PM to 04/08/2024 at 11 PM.  Online application has to be done by 59 hours (in 7 days). Following are the details clarifying the required qualifications for the mentioned vacancy.

Indian Institute of Maize Research looking for Life Sciences candidates
Post Graduate degree in plant Biotechnology, Plant Molecular Biology, Plant Molecular Biology and Biotechnology, Agricultural Biotechnology, Plant Sciences, Biochemistry, Life Sciences
Vacancy for Research Scientist at Regional Centre for Biotechnology
First Class Post Graduate degree in Life Science, with at least two years of research experience in molecular biology from a research institute, university. 
Vacancy for M.Sc, B.Pharm in Quality Control Department at Zydus Lifesciences
To perform all associate activities like reagent preparation, volumetric solution preparation, test solution preparation, factor determination, working standard preparation required for analysis as per approved procedure.